News | April 10, 2026
Zeto gains FDA nod for new outpatient EEG system promising faster brain health testing
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
World MS Day 2026 conclave brings together MPs, neurologists, disability rights advocates and insurance stakeholders to push for reforms in healthcare access, disability recognition and social protection
Baxfendy works in a fundamentally different way from current therapies
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
The approval comes after a systematic review of published literature
Under the deal, Quiver will receive an undisclosed advance payment and research support
Subscribe To Our Newsletter & Stay Updated
